… Since ertapenem and … the pharmacokinetic profile of ertapenem, for which only limited
data are available, and to investigate its impact on the intestinal flora in comparison to those of …

… , these pharmacodynamic principles were applied to human pharmacokinetic data following
administration of ertapenem, 1 g … of bacteria isolated from patients enrolled in the ertapenem …

… the gut microbiota, especially the anaerobic bacteria and the … dosing regimen and
pharmacokinetic parameters is plausible. … treated with ertapenem, moxifloxacin or flomoxef, …

… to alter the pharmacokinetics of ertapenem. Since the liver does not contribute to ertapenem
… hypoalbuminaemia) would impact on ertapenem pharmacokinetics in patients with hepatic …

… The antimicrobial spectrum and pharmacokinetics of ertapenem suggest several potential
… Some readers may think that ertapenem is tailor-made for purposes other than those for …

… Pharmacokinetics of ertapenem in healthy young adults support its use as a once-daily
antibiotic at a dose of 1 g intravenously (iv). Ertapenem is … spectrum, ertapenem seems to be an …

… investigated the pharmacokinetics of total ertapenem in healthy … pharmacokinetic parameters
of total ertapenem were similar across the five studies. The mean CL P of total ertapenem …

… We found that the patients who underwent the use of ertapenem had a significant lower …
Comparing the pharmacokinetics of the three antibiotics, ertapenem and moxifloxacin had a …

… than in those treated with ertapenem. Treatment with antimicrobial agents broadly active
against enteric bacteria has the potential to select for bowel … In turn, bowel flora may provide an …

… The activities of moxifloxacin, imipenem, and ertapenem against pathogens causing severe
necrotizing pancreatitis were studied in an in vitro pharmacokinetics/pharmacodynamics (PK/…